Bain Capital to buy PCI Pharma at $10 billion valuation, Bloomberg News reports
The buyout firm is in discussions with PCI's backers — Kohlberg & Co, Mubadala Investment Co and Partners Group Holding AG — about a deal for a majority stake of the Philadelphia-based drug services provider, the report said. A representative for PCI declined to comment.






